Specializing in allergy disease management
AlleHealth is a allergy disease management service provider. We partner with organizations to build and implement an allergy disease management program.
An estimated 50 million Americans suffer from undiagnosed allergies. There is a nationwide shortage of allergists. Because of this, a large numbers of patients will never be able to see an allergist and receive needed treatment.
We have made it our goal to work with healthcare providers to bring allergy testing and treatment to their patients who need it. A shortage of allergists shouldn't result in anyone not having access to adequate and appropriate medical care.
We provide our partners with state of the art allergy testing, treatment options, triage protocols, and the trained staff necessary to manage their program. We help them offer allergy care to their patients.
A History of Rising To The Call
Throughout the history of modern medicine, whenever there has been a shortage of specialists, Primary Care and other providers have stepped forward to meet the needs of the average routine patients leaving the most seriously ill for the specialists.
EKGs, stress testing, hypertension, coronary artery disease, were once exclusive to cardiologists. Diabetes and hypothyroidism were exclusive to endocrinologists. Depression and anxiety were exclusive to psychiatrists. The examples are too numerous to count.
AlleHealth exists to help our partners fill this new need quickly and easily.
How Do I Know If I Have Allergies?
Common Symptoms Can Include:
Stuffy or Runny Nose
Red or Watery Eyes
Coughing or Sneezing
Unexplained Gastro-Intestinal Distress
Finding out starts with a test
What Are Allergies?
Allergies occur when a patient's immune system reacts inappropriately to a normally harmless substance in the environment.
Allergies develop over time through repeated exposure to allergens
Predisposition to developing allergies is thought to be genetic as well as environmental
The more someone is exposed to an allergen, the more likely it is for them to develop an allergy.
The more subsequent exposures, the more severe the allergic reaction may become.
Note some IgE mediated allergic events appear to occur without any history of prior exposure.
Some food allergies are the result of unlisted contaminants.
Allergies Are An Epidemic
Allergy diseases are increasing worldwide with unprecedented complexity and severity. More than 50 million Americans suffer from allergies, 20% – 25% of the US Population
There is a Shortage of Allergists
With just over 6,000 allergists in 2018, there are not enough allergists to see every patient with allergies.
Allergies Are The Tip of the Iceberg
Allergies usually begin in early childhood as a skin rash, within a few year progress to food allergies, then to a chronic or seasonal stuffy nose, and progress to asthma. This common progression is the "Allergic March."
Asthma is the Leading Chronic Disease in Children
Asthma is the top reason for missed school days. In 2013, approx. 13.8 million missed school days were reported due to asthma. In 2016, one in twelve children aged 0-17 were diagnosed with Asthma.
The Progression Starts Early
In 45% of children, the "Allergic March" starts during the first 6 months of life.
Allergies and Asthma Are Treatable
Childhood intervention with allergy immunotherapy has been shown to slow or even halt the progression of the "Allergic March."
AlleHealth provides our partners with state of the art allergy skin testing, allergy immunotherapy, triage protocols, and the trained staff necessary to manage their program. We work with the medical director of each practice to develop and enact customized diagnostic and treatment protocols using evidence based research.
Skin prick testing is the standard of care and is the same test performed by Allergists. They are routinely performed for "aeroallergens" (dusts, animal hair, pollens, and molds) and "food allergens" (peanuts, tree nuts, milk, wheat, soybean, fish, and shellfish).
Painless. Fast. Reliable.
Allergy Immunotherapy was first discovered in 1911, over one hundred years ago. It is the process of administering very tiny dilute doses of the substances to which patients are allergic. By starting with a very tiny dilute amount and gradually increasing the dose, Allergy Immunotherapy allows the patient's immune system to "get used to" and tolerate the substances to which they are allergic. Approximately 85% of patients receiving Allergy Immunotherapy will have their allergy and asthma symptoms significantly improve or completely disappear.
Unlike symptomatic treatment, allergy immunotherapy treats the root cause of allergies, rather than just the symptoms. It has been shown prevent the development of new allergies as well as treating ones a patient already has.